Drreddys Laboratories reported $278.21B in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Ani Pharmaceuticals ANIP:US $ 480.16M 16.32M
Aphria Inc APH:CN C$ 2.81B 5.48M
Aurora Cannabis Inc ACB:CN 2.6B 230.63M
Bayer BAYN:GR € 114427M 4350M
Canopy Growth Corp WEED:CN C$ 6.97B 143M
Catalent CTLT:US $ 9112M 342.9M
Corcept Therapeutics CORT:US $ 568.48M 16.08M
Drreddys Laboratories RDY:US $ 278214M 12723M
Endo International Ordinary Shares ENDP:US $ 9206.26M 27.91M
GlaxoSmithKline GSK:LN 77011M 1068M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Hikma Pharmaceutical HIK:LN 4.18B 45M
Horizon Pharma HZNP:US $ 8207.42M 360.81M
JAZZ PHA JAZZ:US $ 13212.99M 6456.52M
Lannett LCI:US $ 683.74M 178.63M
Lonza Group LONN:SW 15.16B 732M
Novartis NOVN:VX SF 124015M 2263M
Pacira Pharmaceuticals PCRX:US $ 1325.83M 38.28M
Phibro Animal Health PAHC:US $ 841.32M 36.31M
Prestige Brands PBH:US $ 3559.11M 129.84M
Richter Gedeon RICHT:HB 1040.82B 74.11B
Supernus Pharmaceuticals SUPN:US $ 1573.06M 65.62M
Teva Pharmaceutical TEVA:IT 49.2B 191M